Mazen El-Hammadi

Prof. Mazen El-Hammadi

Universidad de Sevilla
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MEMazen El-Hammadi
Mazen El-Hammadi
José Luis Arias MedianoJosé Luis Arias Mediano
José Luis Arias Mediano
Therapeutics are habitually characterized by short plasma half-lives and little affinity for targeted cells. To overcome these challenges, nanoparticulate systems have entered into the disease arena. Poly(d,l-lactide-co-glycolide) (PLGA) is one of the most relevant biocompatible materials to construct drug nanocarriers. Understanding the physical chemistry of this copolymer and current knowledge of its biological fate will help in engineering efficient PLGA-based nanomedicines. Surface modification of the nanoparticle structure has been proposed as a required functionalization to optimize the performance in biological systems and to localize the PLGA colloid into the site of action. In this review, a background is provided on the properties and biodegradation of the copolymer. Methods to formulate PLGA nanoparticles, as well as their in vitro performance and in vivo fate, are briefly discussed. In addition, a special focus is placed on the analysis of current research in the use of surface modification strategies to engineer PLGA nanoparticles, i.e., PEGylation and the use of PEG alternatives, surfactants and lipids to improve in vitro and in vivo stability and to create hydrophilic shells or stealth protection for the nanoparticle. Finally, an update on the use of ligands to decorate the surface of PLGA nanomedicines is included in the review.

1 January 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MEMazen El-Hammadi
Mazen El-Hammadi
Angel V. DelgadoAngel V. Delgado
Angel V. Delgado
CMConsolación Melguizo
Consolación Melguizo
JPJosé C. Prados
José C. Prados
José Luis Arias MedianoJosé Luis Arias Mediano
José Luis Arias Mediano

22 April 2015 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
Ahmad AgilAhmad Agil
Ahmad Agil
MEMazen El-Hammadi
Mazen El-Hammadi
AJAroa Jiménez‐Aranda
Aroa Jiménez‐Aranda
MTMohamed Tassi
Mohamed Tassi
WAWalied Abdo
Walied Abdo
RRRussel J. Reiter
Russel J. Reiter

19 November 2011 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
MEMazen El-Hammadi
Mazen El-Hammadi
NANisrine Awad
Nisrine Awad

1 June 2021 in Industrial Crops and Products
Verified
Journal Article
Closed access
MEMazen El-Hammadi
Mazen El-Hammadi
ASAndrea L. Small-Howard
Andrea L. Small-Howard
MFMercedes Fernández-Arévalo
Mercedes Fernández-Arévalo
LMLucía Martín-Banderas
Lucía Martín-Banderas

10 March 2015 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
MEMazen El-Hammadi
Mazen El-Hammadi
José Luis Arias MedianoJosé Luis Arias Mediano
José Luis Arias Mediano
Iron oxide nanoparticles (IO NPs) exhibit remarkable properties, including inherent magnetism, biocompatibility, high surface to volume ratio, and versatility of engineering, making them ideal candidates for a variety of clinical applications. The review provides an in-depth discussion on recent patents and developments related to IO NPs in Biomedicine from the last 7 years. It covers innovations in the chemical synthesis, surface coating and functionalization, and biomedical applications, including MRI and multimodal imaging, molecular imaging, cell labeling, drug delivery, hyperthermia, hyperphosphatemia, and antibacterial activity. A brief outline of the important properties of IO NPs is also presented. The main focus of current research is the development of new approaches to generate high-quality IO NPs with optimal properties in terms of particle geometry, crystal structure, surface functionalities, stability, and magnetization. Among chemical synthesis methods, thermal decomposition and hydrothermal synthetics processes allow fine control of the particle properties. Plenty of coating materials have been successfully used as shells for these NPs to provide colloidal stability, even enabling the formulation of nanotheranostics for simultaneous disease diagnosis and therapy. However, long-term toxicity and pharmacokinetic studies are necessary before magnetic nanosystems can be approved for clinical use.